Literature DB >> 29788098

Helicobacter pylori Colonization Protects Against Chronic Experimental Colitis by Regulating Th17/Treg Balance.

Hongchen Zhang1, Yun Dai1, Yun Liu1, Ting Wu1, Jing Li1, Xiaolei Wang1, Weihong Wang1.   

Abstract

Background: Epidemiological studies have demonstrated an inverse association between Helicobacter pylori infection and the risk of developing inflammatory bowel disease (IBD). The mechanisms by which H. pylori infection protects against IBD are unclear. Here, we explored the possible protective effects and mechanisms of gastric H. pylori colonization on a chronic colitis model, with focus on whether H. pylori exerted its effects through regulating Th17/Treg immune responses.
Methods: Chronic colitis was induced by dextran sulfate sodium (DSS) treatment. Flow cytometry analysis was performed to determine Th17 cells, Treg cells, and M1/M2 macrophages in the spleen, mesenteric lymph nodes, and colonic lamina propria. The levels of Th17- and Treg-associated cytokines were measured by quantitative polymerase chain reaction. The direct effect of H. pylori extract on the polarization status of macrophages was determined in vitro.
Results: Gastric H. pylori colonization significantly ameliorated the severity of chronic DSS-induced colitis. H. pylori colonization decreased Th17 cells and mRNA levels of IL-17A, IL-17F, and IL-21 in the colon. Simultaneously, H. pylori colonization increased Treg cells and IL-10 expression. As to cytokines driving Th17 and Treg differentiation, H. pylori colonization increased TGFβ and decreased IL-6 and IL-23. Moreover, H. pylori colonization significantly increased M2 macrophages in the colon. In vitro, H. pylori extract promotion of M2 macrophage polarization was dependent on the presence of CagA. Conclusions: H. pylori colonization protects against chronic DSS-induced colitis via balancing Th17/Treg responses and shifting macrophages toward anti-inflammatory M2 phenotype. Our results strengthen the rationale for gastric H. pylori colonization affecting the immune homeostasis of the colon.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29788098     DOI: 10.1093/ibd/izy107

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  16 in total

1.  Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.

Authors:  Adam Tepler; Neeraj Narula; Richard M Peek; Anish Patel; Cyrus Edelson; Jean-Frederic Colombel; Shailja C Shah
Journal:  Aliment Pharmacol Ther       Date:  2019-06-05       Impact factor: 8.171

2.  Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent manner.

Authors:  Marianne R Spalinger; Thomas Sb Schmidt; Marlene Schwarzfischer; Larissa Hering; Kirstin Atrott; Silvia Lang; Claudia Gottier; Annelies Geirnaert; Christophe Lacroix; Xuezhi Dai; David J Rawlings; Andrew C Chan; Christian von Mering; Gerhard Rogler; Michael Scharl
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 3.  Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment.

Authors:  Linqi Zhu; Yue Huang; Hong Li; Shihe Shao
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-20       Impact factor: 4.813

4.  Synthesis of Interleukin-10 in Patients with Ulcerative Colitis and Helicobacter pylori Infection.

Authors:  Jesús K Yamamoto-Furusho; Gabriela Fonseca-Camarillo; Carlos A Barrera-Ochoa; Janette Furuzawa-Carballeda
Journal:  Gastroenterol Res Pract       Date:  2020-07-06       Impact factor: 2.260

5.  Systematic review: gastrointestinal infection and incident inflammatory bowel disease.

Authors:  Jordan E Axelrad; Ken H Cadwell; Jean-Frederic Colombel; Shailja C Shah
Journal:  Aliment Pharmacol Ther       Date:  2020-05-05       Impact factor: 8.171

6.  Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation.

Authors:  Zhengqi Wang; Tamisha Y Vaughan; Wandi Zhu; Yuhong Chen; Guoping Fu; Magdalena Medrzycki; Hikaru Nishio; Silvia T Bunting; Pamela A Hankey-Giblin; Asma Nusrat; Charles A Parkos; Demin Wang; Renren Wen; Kevin D Bunting
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

Review 7.  Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System.

Authors:  Bei Yue; Xiaoping Luo; Zhilun Yu; Sridhar Mani; Zhengtao Wang; Wei Dou
Journal:  Microorganisms       Date:  2019-10-11

8.  Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses.

Authors:  Jan Kevin Maerz; Constanze Trostel; Anna Lange; Raphael Parusel; Lena Michaelis; Andrea Schäfer; Hans Yao; Hanna-Christine Löw; Julia-Stefanie Frick
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

9.  The Degree of Helicobacter pylori Infection Affects the State of Macrophage Polarization through Crosstalk between ROS and HIF-1α.

Authors:  Ying Lu; Jianfang Rong; Yongkang Lai; Li Tao; Xiaogang Yuan; Xu Shu
Journal:  Oxid Med Cell Longev       Date:  2020-12-08       Impact factor: 6.543

10.  Helicobacter pylori infection reduces TAMs infiltration in a mouse model of AOM/DSS induced colitis-associated cancer.

Authors:  Luo-Na Li; Yun Liu; Hong-Chen Zhang; Ting Wu; Yun Dai; Wei-Hong Wang
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.